Cloniprazepam is primarily utilized in research as a prodrug of Clonazepam, designed to shed light on metabolic conversion, receptor binding, and behavioral pharmacology. It’s especially useful in evaluating the transformation process of benzodiazepines in vitro and in vivo. Research with Cloniprazepam helps scientists better understand the long-acting effects and pharmacokinetics of benzodiazepine analogs.

• Prodrug Conversion Studies:
  Cloniprazepam is metabolically converted into Clonazepam, making it valuable for examining the activation and timing of prodrug compounds in biological systems.

• GABA-A Receptor Binding Research:
  It interacts with the GABA-A receptor complex, allowing researchers to study its modulatory effects on inhibitory neurotransmission in both isolated and complex systems.

• Pharmacokinetic Profiling:
  Its unique metabolism enables detailed investigation into how chemical structure affects absorption, distribution, metabolism, and excretion (ADME) profiles.

• Sedative-Hypnotic Modeling:
  Cloniprazepam is used to simulate long-acting sedative effects in rodent or in vitro models for neuropharmacological benchmarking.

• Toxicology and Forensic Detection:
  Laboratories studying synthetic benzodiazepines often include Cloniprazepam in toxicology screens, particularly in identifying emerging designer drug analogs.

• Comparative Benzodiazepine Analysis:
  Researchers compare Cloniprazepam with structurally related analogs to map out behavioral differences, therapeutic window variations, and onset/duration shifts.

• Neurochemical Impact Studies:
  Cloniprazepam serves as a benchmark to explore how GABAergic agents modulate neurotransmitter release, especially in anxiety and epilepsy research simulations.

The legal status of Cloniprazepam depends heavily on the region, as many countries do not classify it under specific drug control schedules. As an unscheduled research chemical in several jurisdictions, it is typically available for scientific use — provided it is not intended for human consumption.

• Unscheduled in Many Regions:
  Cloniprazepam is not classified as a controlled substance in several countries, which permits its sale for legitimate laboratory research purposes.

• Subject to Local Laws:
  Researchers must verify that Cloniprazepam complies with national or regional regulations before placing an order. Some countries may regulate it under analogue laws or prescription classifications.

• RC Plug Compliance Policy:
  We do not ship Cloniprazepam to jurisdictions where it is scheduled or clearly restricted. Orders from restricted countries are flagged and declined before fulfillment.

• Documentation Support Available:
  Upon request, we provide Certificates of Analysis (COA), Safety Data Sheets (SDS), and shipping manifests to help with customs clearance or legal review.

• Not for Human Use Disclaimer:
  All Cloniprazepam sold by RC Plug is strictly for research and analytical purposes. We label our products accordingly to comply with safety and regulatory expectations.

• Import Risk Responsibility:
  Buyers are responsible for confirming that importation complies with local laws. We encourage all customers to consult relevant government agencies or regulatory authorities.

Cloniprazepam is a synthetic triazolobenzodiazepine with a chemical configuration that positions it as both a functional analog and a prodrug of Clonazepam. Its molecular structure directly impacts its bioactivity and pharmacokinetics.

• Core Scaffold – Triazolobenzodiazepine:
  The compound features a triazole ring fused to a traditional diazepine backbone, distinguishing it from classical benzodiazepines by its increased binding affinity and metabolic pathway.

• Substituent Groups:
  Cloniprazepam contains a chlorine atom on the phenyl ring, a fluorine atom contributing to lipophilicity, and a nitro group at the 7-position, enhancing GABA-A receptor affinity.

• Prodrug Dynamics:
  The compound is metabolized into active Clonazepam through biotransformation, making its structural flexibility crucial for timed-release activity in pharmacokinetic studies.

• IUPAC Name:
  The official IUPAC name is 5-(2-chlorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one, which reflects its systematic atomic structure.

• Molecular Formula:
  C18H13ClFN3O2 – the presence of halogens (Cl and F) and nitrogenous functional groups contributes to high receptor selectivity and stability.

• Molecular Weight:
  The compound weighs approximately 357.8 g/mol, a parameter useful in preparing accurate dosages for solubility and reactivity experiments.

Cloniprazepam is studied for its sedative, anxiolytic, and muscle relaxant analog effects, all of which are relevant to GABAergic research models. It exhibits delayed onset due to its prodrug nature, but once activated, it produces long-lasting effects similar to Clonazepam.

• Delayed Activation:
  As a prodrug, Cloniprazepam requires metabolic conversion before manifesting pharmacological activity, which makes it valuable in extended-duration behavioral models.

• GABA-A Receptor Modulation:
  It acts as a positive allosteric modulator, enhancing the effects of GABA neurotransmitters and inducing anxiolytic and hypnotic-like behaviors in laboratory animals.

• Long Duration of Action:
  After conversion, the active metabolite produces prolonged effects, supporting research into sustained-release formulations or extended therapeutic coverage.

• Muscle Relaxant Analog Properties:
  Cloniprazepam mimics the central muscle relaxant profile of classical benzodiazepines and is useful in studying neuroinhibition across spinal and cortical networks.

• Comparative Pharmacology:
  It’s frequently compared to other benzodiazepines to assess receptor subtype selectivity, dose-response relationships, and tolerance thresholds.

• Neurobehavioral Assessment Models:
  Cloniprazepam is used in maze, locomotor, and behavioral suppression studies to quantify its impact on anxiety, alertness, and motor coordination.

Proper storage is essential to maintain the chemical stability and integrity of Cloniprazepam. This ensures accurate results across research sessions and prevents degradation or contamination that can compromise data validity.

• Ideal Temperature Range:
  Store between 2–8°C in a cool, dry environment to avoid degradation caused by heat or humidity. A refrigerator or temperature-controlled chemical cabinet is preferred.

• Humidity Control:
  Avoid storing in moist or open environments. Exposure to air and moisture can lead to hydrolysis, reducing potency and altering structure.

• Protect From Light:
  UV exposure can degrade active compounds. Always store Cloniprazepam in opaque, amber-colored containers or in its original sealed packaging.

• Keep Tightly Sealed:
  After each use, ensure the container is sealed tightly. Minimize air exposure to preserve stability, especially in powder form.

• Avoid Frequent Handling:
  Minimize how often you open and expose the compound to air. If using pellets, remove only the required number per experiment to reduce unnecessary exposure.

• Label and Date Each Container:
  Label each vial with the batch number and date of opening to help track shelf life and ensure reproducibility in long-term studies.

Cloniprazepam and Clonazolam are both potent triazolobenzodiazepines, but they differ significantly in their pharmacological profiles, metabolic behavior, and research utility. Understanding their differences is essential for researchers studying benzodiazepine analogs, especially those focused on prodrug dynamics, potency, and onset duration.

• Prodrug vs. Direct Agonist:
  Cloniprazepam is a prodrug of Clonazepam, requiring metabolic conversion for full activity. Clonazolam, by contrast, is pharmacologically active without requiring transformation, resulting in more immediate onset.

• Onset and Duration:
  Clonazolam is known for its rapid onset and intense, short-term potency, often peaking quickly. Cloniprazepam exhibits a slower onset but provides a longer, sustained effect post-metabolism.

• Potency Comparison:
  Clonazolam is considered more potent by weight, often requiring microgram-level dosing in studies. Cloniprazepam is slightly less potent per unit mass but exhibits greater duration, making it suitable for extended observation models.

• Research Applications:
  Clonazolam is frequently studied for its acute sedative effects, while Cloniprazepam is preferred for chronic models or metabolism-based research due to its prodrug nature.

• Safety Margin in Lab Use:
  Due to its high potency, Clonazolam presents greater risk for dosing errors. Cloniprazepam’s delayed activation offers more controlled dosing conditions in lab settings.

• Metabolic Pathway Differences:
  Cloniprazepam must be hydrolyzed by liver enzymes, offering insight into hepatic transformation. Clonazolam undergoes minor biotransformation, allowing direct comparison between prodrug and non-prodrug analogs.

Cloniprazepam is typically distributed in powder or pellet form, with both formats suited for specific research environments. Each form is prepared under sterile, controlled conditions to ensure consistency and high-purity delivery to researchers.

• Powder Form:
  Ideal for researchers conducting solution-based or volumetric dosing studies. It allows flexibility in creating custom concentrations for spectrometry, chromatography, or solubility trials.

• Pellet Form:
  Pellets are pre-dosed and standardized, making them ideal for controlled testing protocols or behavioral observation models where consistent amounts are critical.

• Purity Assurance:
  Regardless of form, our Cloniprazepam is ≥ 99% pure, verified through HPLC and NMR analysis. Both powder and pellets originate from the same synthesized batch.

• Storage Stability:
  Both forms are packaged in airtight, light-resistant containers and can be safely stored for up to 24 months under recommended conditions.

• Batch Customization Available:
  For institutional or bulk orders, we can accommodate custom pellet sizes or powder weights based on research requirements.

• Handling Requirements:
  While pellets offer minimal handling, powder requires use of appropriate PPE and calibrated lab equipment for precision in measurement and transfer.

No, Cloniprazepam sold by RC Plug is strictly intended for laboratory research use only. It is not approved for human or veterinary consumption and should never be used outside of controlled research environments.

• Research-Only Declaration:
  Each shipment includes a disclaimer and labeling that restricts the compound to laboratory use under controlled conditions.

• Not Evaluated for Safety in Humans:
  Cloniprazepam has not undergone the clinical testing required for human consumption approval by regulatory agencies such as the FDA or EMA.

• Legal Liability and Ethics:
  Using this compound in human studies may result in serious legal and ethical consequences. Researchers must comply with chemical safety and human-subject protection protocols.

• No Prescription-Based Dispensation:
  As an unscheduled research chemical, Cloniprazepam cannot legally be used in therapeutic or diagnostic procedures on humans.

• Potential Health Risks:
  Without proper human safety data, side effects, toxicity thresholds, and pharmacodynamics remain unverified in clinical contexts.

• Restricted Use Enforcement:
  We actively monitor orders and accounts for signs of misuse and reserve the right to decline or cancel purchases intended for improper applications.

In laboratory settings, Cloniprazepam demonstrates a moderate onset and long-lasting duration of effect, largely due to its nature as a prodrug. These characteristics make it a valuable compound in long-duration pharmacology models.

• Delayed Onset Due to Prodrug Status:
  Cloniprazepam must first undergo metabolic conversion to Clonazepam, resulting in a slower onset, typically observable after enzymatic processing in vitro or in vivo.

• Extended Duration of Effect:
  Once activated, it maintains long-lasting sedative and anxiolytic analog effects, which can persist up to 8–12 hours in receptor-based studies.

• Ideal for Sustained Observations:
  Its timeline suits chronic dosing or long-term exposure simulations, particularly where researchers need to observe long windows of GABAergic modulation.

• Stable Plasma Presence (in simulated models):
  Cloniprazepam’s converted metabolites remain stable across time in most simulated metabolism scenarios, allowing extended behavioral or receptor tracking.

• Less Frequent Dosing Required:
  Compared to shorter-acting benzodiazepines, fewer applications of Cloniprazepam are necessary within a test cycle, improving study precision.

At RC Plug, we ensure that our Cloniprazepam is of the highest research-grade purity, making it suitable for even the most sensitive lab protocols. Each batch is ≥ 99% pure, verified through comprehensive, third-party testing.

• HPLC (High-Performance Liquid Chromatography):
  We use HPLC to confirm compound purity and detect trace byproducts. Each sample must meet or exceed the 99% standard threshold before approval.

• NMR Spectroscopy Verification:
  Nuclear Magnetic Resonance (NMR) is used to authenticate molecular structure and ensure compound identity matches IUPAC specification.

• Mass Spectrometry Cross-Validation:
  Select batches are analyzed via MS to confirm the exact molecular weight and to screen for non-volatile impurities.

• Batch-Specific COAs:
  Every purchase can be accompanied by a Certificate of Analysis confirming purity, structural confirmation, and lot number documentation.

• No Residual Solvent Contamination:
  Our post-synthesis purification methods remove all residual solvents, reducing the risk of interference in delicate chemical assays.

• Packaged in Controlled Environments:
  We use clean-room grade facilities for packaging to prevent cross-contamination and degradation during handling and shipment.

Yes — at RC Plug, we provide a real-time tracking number for every Cloniprazepam order, ensuring you remain fully informed throughout the shipping process. Tracking transparency is one of the cornerstones of our commitment to secure and accountable delivery.

• Automatic Email Notification:
  Once your order is processed and dispatched, you’ll receive an email containing your unique tracking number, carrier information, and estimated delivery timeframe.

• Real-Time Updates:
  Our tracking system is fully integrated with global logistics networks, allowing you to monitor your shipment from the moment it leaves our facility to final delivery.

• Secure Tracking Link:
  The tracking link provided ensures encrypted, direct access to your shipment’s location, reducing third-party exposure and maintaining your privacy.

• Tracking for All Shipping Methods:
  Regardless of whether you select standard or express delivery, all packages come with tracking — including overnight shipments in eligible countries.

• Discreet Delivery with Tracking:
  The tracking number is attached to a discreetly packaged order with no mention of product name or sender identity, preserving total confidentiality.

• Customer Support Integration:
  Our support team monitors shipment activity and is available to assist with delivery updates or carrier contact if any delay or issue arises.

At RC Plug, we prioritize both payment privacy and flexibility. That’s why we offer a range of anonymous and secure payment methods while avoiding credit cards, which often require unnecessary identity verification.

• Bitcoin (Preferred for Anonymity):
  Bitcoin is the most private, decentralized payment option available. Transactions are encrypted, fast, and require no personal banking data.

• Zelle:
  For U.S.-based customers, Zelle offers a direct bank-to-bank transfer method. It’s quick, accessible, and doesn’t require third-party processors.

• CashApp:
  CashApp provides an easy-to-use platform for sending payments with speed and reliability. It’s ideal for mobile and app-based transactions.

• Western Union:
  We accept Western Union for customers who prefer to handle transfers via agent locations or who are located in regions with limited access to banking services.

• Bank Transfer:
  Institutional clients and repeat customers can also pay via direct bank transfer. This method is stable, traceable, and excellent for bulk orders.

• No Credit Card Payments:
  We do not accept credit or debit cards at this time. This helps maintain high levels of payment confidentiality and avoid identity exposure through banking intermediaries.

• Payment Instructions Provided at Checkout:
  Once your preferred method is selected during checkout, you’ll receive clear, step-by-step payment instructions.

We stand behind the quality and integrity of every order — that’s why our Cloniprazepam purchases are backed by a 30-day full refund or free replacement guarantee. If your package is lost, delayed, or arrives damaged, your satisfaction is fully protected.

• 30-Day Full Refund Window:
  If your order fails to arrive within 30 days of shipment or is confirmed as lost, we will issue a full refund to your original payment method.

• Free Replacement Option:
  Alternatively, you may choose to have your Cloniprazepam re-shipped at no additional cost. This is often preferred for time-sensitive research projects.

• No Questions Asked:
  Our return policy is designed to be fast and uncomplicated — we do not require you to explain the issue or provide extended documentation.

• Package Damage Coverage:
  If your order is physically damaged upon arrival, we will replace the entire shipment free of charge. Photos of the damage are helpful but not mandatory.

• Incorrect Product Coverage:
  In the rare case of a packing error, we’ll resend the correct item immediately at our cost — with no return of the incorrect item required.

• Policy Activation:
  Contact our support team with your order ID, tracking number, and issue summary. We typically resolve refund or replacement claims within 24–48 hours.

Yes. We maintain a rigorous multi-tiered testing protocol to ensure that every batch of Cloniprazepam we offer is free from harmful contaminants and meets the highest research chemical standards. All tests are conducted in qualified laboratories.

• Residual Solvent Testing:
  Post-synthesis analysis ensures that no solvent residues — such as acetone, ethanol, or hexane — remain above trace levels in the final product.

• Heavy Metal Screening:
  Our lab tests for the presence of heavy metals (e.g., lead, cadmium, arsenic, mercury), which can appear in impure manufacturing processes but are strictly removed in ours.

• Microbial Purity Assurance:
  While Cloniprazepam is a synthetic compound, batches are nonetheless checked for microbial contaminants during final packaging in clean-room conditions.

• Chromatographic Purity:
  High-performance liquid chromatography (HPLC) is used not only to determine purity but also to flag any unexpected peaks that may indicate decomposition or contamination.

• Cross-Contamination Prevention:
  All synthesis and packaging are performed in segregated, sterile facilities to prevent cross-contamination with other chemical compounds.

• Certification Available:
  Each batch is supported by a Certificate of Analysis (COA) detailing the testing results and confirming that the product meets our ≥ 99% purity standard.

Cloniprazepam is particularly valued in long-term and extended-duration research models because of its prodrug activation, sustained effects, and predictable pharmacokinetics. These properties make it ideal for studies where consistent modulation over time is essential.

• Long-Lasting Active Metabolite:
  Upon biotransformation, Cloniprazepam yields Clonazepam, which maintains stable concentrations over extended periods — ideal for time-course receptor or behavioral assays.

• Reduced Dosing Frequency:
  Its prolonged effect means fewer administrations are needed, reducing variability and improving the consistency of data in chronic testing models.

• Prodrug Activation Insight:
  Its status as a prodrug allows researchers to explore drug metabolism pathways, enzyme interactions, and activation timelines.

• Minimized Accumulation Risk:
  When dosed correctly, Cloniprazepam shows minimal residual accumulation, making it easier to interpret long-term effects without interference from previous doses.

• Well-Tolerated in Lab Models:
  In preclinical studies (e.g., rodent models), Cloniprazepam analogs are observed to exhibit stable sedation levels without inducing extreme central depression, allowing safer longitudinal testing.

• Receptor Desensitization Studies:
  Its extended GABA-A receptor engagement helps examine tolerance development and desensitization processes, crucial in neuropharmacological research.

Handling Cloniprazepam in a laboratory setting requires strict adherence to chemical safety protocols to prevent accidental exposure, contamination, or misapplication. As a potent triazolobenzodiazepine derivative, it must be treated with care even in small quantities.

• Use Personal Protective Equipment (PPE):
  Always wear disposable gloves, protective goggles, and a lab coat when handling Cloniprazepam to avoid skin contact and accidental ingestion or inhalation.

• Work in a Controlled Environment:
  Conduct all measurements and transfers within a fume hood or well-ventilated lab space to reduce risk of airborne particle exposure.

• Use Precision Equipment:
  For powdered Cloniprazepam, always use analytical-grade balances and calibrated micro-spatulas to ensure accurate, contamination-free dosing.

• Avoid Cross-Contamination:
  Clean all surfaces and equipment before and after use. Designate separate containers and utensils exclusively for Cloniprazepam.

• Seal and Store Immediately After Use:
  Reseal original containers after handling to prevent air, moisture, or light from compromising the compound.

• Label Clearly and Store Securely:
  Label all storage vials clearly with compound name, concentration (if prepared), and date opened. Store away from other chemicals in a locked, climate-controlled location.

• Disposal Compliance:
  Dispose of any waste or contaminated materials in accordance with local hazardous chemical disposal regulations. Never discard in regular trash or sinks.